The Cell-NCI Symposium: Beyond Cancer Genomics Toward Precision Oncology is taking place virtually from October 4-6, 2021 and will showcase multi-omics approaches to functional characterization of candidate cancer drug targets. Register before October 2.
The mission of the NCI’s Office of Cancer Genomics (OCG) is to advance the molecular understanding of cancers with the goal to improve patient outcomes. OCG supports structural, functional, and translational genomic programs, as well as the development of next generation cancer models, to accelerate the translation of findings into the clinic and contribute to precision oncology.
The OCG furthers its mission to advance and accelerate genomics science by disseminating the data and resources generated by OCG supported programs to the research community.